Ovation Science announced it has entered into an exclusive agreement with Skincareguide.com Ltd. to act as the Company’s Medical Dermatology Advisory Board for cannabis formulated products.

Ovation Science Inc. unveiled the launch of its new topical skincare product line infused with hemp-derived cannabidiol (“CBD”) called ARLO Beauty.

This first-to-market recreational cannabis product has been formulated to quickly deliver a high-dose of THC into the blood stream (transdermal). This new product is marketed and distributed in the USA by Cannabiniers under the name BASKiN GLOW.

January 15, 2019. We wanted to inform you that Small Cap Power has begun coverage of Ovation Science Inc. Here is the link to the coverage: https://smallcappower.com/companies/ovat/articles/ovation-science-stock-cbd/ Best regards, Terry Howlett President & CEO

Ovation Science Inc. announced today that the passing of the 2018 Farm Bill in the USA as well as Health Canada’s draft regulations for cannabis topicals, both have the potential to positively impact Ovation’s business.

Ovation Science Inc. a skincare research and development company with the objective to be the leader in the topical and transdermal cannabis market by leveraging its patented skin delivery technology, announces the launch of a third product in the USA by its licensee.

At the inaugural 2018 New Green Frontier cannabis investor conference attendees had the opportunity to hear from the VP Business Development of Ovation Science Inc (CSE: OVAT), Doreen McMorran.

Ovation Science (CSE:OVAT) President and CEO Terry Howlett joined Steve Darling in the Vancouver office of Proactive Investors to share details of their patented technology Invisicare that will deliver CBD and THC through the skin.

Vancouver, BC – November 15, 2018 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) announces that it has closed its Initial Public Offering of units at $0.30 per unit (the “Units”) pursuant to its final prospectus dated October 26, 2018 (the “Prospectus”).